South Korea · Delayed Price · Currency is KRW Aimed Bio Statistics
Total Valuation
Aimed Bio has a market cap or net worth of KRW 1.75 trillion. The enterprise value is 1.66 trillion.
| Market Cap | 1.75T |
| Enterprise Value | 1.66T |
Important Dates
The next estimated earnings date is Thursday, August 20, 2026.
| Earnings Date | Aug 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Aimed Bio has 64.67 million shares outstanding. The number of shares has increased by 83.25% in one year.
| Current Share Class | 64.67M |
| Shares Outstanding | 64.67M |
| Shares Change (YoY) | +83.25% |
| Shares Change (QoQ) | +0.65% |
| Owned by Insiders (%) | 34.37% |
| Owned by Institutions (%) | 17.49% |
| Float | 22.61M |
Valuation Ratios
The trailing PE ratio is 45.32.
| PE Ratio | 45.32 |
| Forward PE | n/a |
| PS Ratio | 26.19 |
| PB Ratio | 8.56 |
| P/TBV Ratio | 8.62 |
| P/FCF Ratio | 181.97 |
| P/OCF Ratio | 162.32 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 85.38, with an EV/FCF ratio of 172.49.
| EV / Earnings | 42.96 |
| EV / Sales | 30.60 |
| EV / EBITDA | 85.38 |
| EV / EBIT | 92.43 |
| EV / FCF | 172.49 |
Financial Position
The company has a current ratio of 17.33, with a Debt / Equity ratio of 0.01.
| Current Ratio | 17.33 |
| Quick Ratio | 16.63 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | 0.16 |
| Interest Coverage | 174.08 |
Financial Efficiency
Return on equity (ROE) is 25.93% and return on invested capital (ROIC) is 10.11%.
| Return on Equity (ROE) | 25.93% |
| Return on Assets (ROA) | 9.85% |
| Return on Invested Capital (ROIC) | 10.11% |
| Return on Capital Employed (ROCE) | 11.79% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.43 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -10.21B |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 24,084.80 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 61.01 |
| Average Volume (20 Days) | 165,933 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Aimed Bio had revenue of KRW 66.79 billion and earned 38.60 billion in profits. Earnings per share was 588.54.
| Revenue | 66.79B |
| Gross Profit | 66.79B |
| Operating Income | 24.22B |
| Pretax Income | 28.38B |
| Net Income | 38.60B |
| EBITDA | 25.83B |
| EBIT | 24.22B |
| Earnings Per Share (EPS) | 588.54 |
Balance Sheet
The company has 92.67 billion in cash and 1.57 billion in debt, with a net cash position of 91.09 billion or 1,408.58 per share.
| Cash & Cash Equivalents | 92.67B |
| Total Debt | 1.57B |
| Net Cash | 91.09B |
| Net Cash Per Share | 1,408.58 |
| Equity (Book Value) | 204.45B |
| Book Value Per Share | 3,155.87 |
| Working Capital | 107.40B |
Cash Flow
In the last 12 months, operating cash flow was 10.78 billion and capital expenditures -1.16 billion, giving a free cash flow of 9.61 billion.
| Operating Cash Flow | 10.78B |
| Capital Expenditures | -1.16B |
| Depreciation & Amortization | 1.61B |
| Net Borrowing | -674.72M |
| Free Cash Flow | 9.61B |
| FCF Per Share | 148.65 |
Margins
Gross margin is 100.00%, with operating and profit margins of 36.26% and 57.79%.
| Gross Margin | 100.00% |
| Operating Margin | 36.26% |
| Pretax Margin | 42.50% |
| Profit Margin | 57.79% |
| EBITDA Margin | 38.67% |
| EBIT Margin | 36.26% |
| FCF Margin | 14.39% |
Dividends & Yields
Aimed Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -83.25% |
| Shareholder Yield | -83.25% |
| Earnings Yield | 2.21% |
| FCF Yield | 0.55% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Aimed Bio has an Altman Z-Score of 251.96 and a Piotroski F-Score of 3.
| Altman Z-Score | 251.96 |
| Piotroski F-Score | 3 |